ICON Public Limited Company (ICLR)
USD 204.4
(0.56%)
USD 204.4
(0.56%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 3.93 Billion USD | -17.71% |
| 2022 | 4.78 Billion USD | -14.47% |
| 2021 | 5.59 Billion USD | 1190.51% |
| 2020 | 433.61 Million USD | -4.61% |
| 2019 | 454.55 Million USD | 30.15% |
| 2018 | 349.26 Million USD | 0.11% |
| 2017 | 348.88 Million USD | 0.11% |
| 2016 | 348.51 Million USD | -0.43% |
| 2015 | 350 Million USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | 0.0% |
| 2011 | - USD | -100.0% |
| 2010 | 200 Thousand USD | -33.33% |
| 2009 | 300 Thousand USD | -99.72% |
| 2008 | 106.17 Million USD | 11.91% |
| 2007 | 94.87 Million USD | 1737.65% |
| 2006 | 5.16 Million USD | 3.1% |
| 2005 | 5 Million USD | 2404.0% |
| 2004 | 200 Thousand USD | -97.19% |
| 2003 | 7.12 Million USD | -39.33% |
| 2002 | 11.74 Million USD | 1.97% |
| 2001 | 11.51 Million USD | 315.51% |
| 2000 | 2.77 Million USD | -23.0% |
| 1999 | 3.6 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 3.64 Billion USD | -7.45% |
| 2024 Q3 | 3.43 Billion USD | -0.15% |
| 2024 Q2 | 3.58 Billion USD | -1.69% |
| 2023 Q2 | 4.44 Billion USD | -3.91% |
| 2023 FY | 3.93 Billion USD | -17.71% |
| 2023 Q1 | 4.62 Billion USD | -3.43% |
| 2023 Q4 | 3.93 Billion USD | -5.4% |
| 2023 Q3 | 4.16 Billion USD | -6.26% |
| 2022 Q3 | 4.97 Billion USD | -4.17% |
| 2022 FY | 4.78 Billion USD | -14.47% |
| 2022 Q1 | 5.29 Billion USD | -5.35% |
| 2022 Q2 | 5.19 Billion USD | -1.95% |
| 2022 Q4 | 4.78 Billion USD | -3.83% |
| 2021 FY | 5.59 Billion USD | 1190.51% |
| 2021 Q1 | 400.77 Million USD | -7.57% |
| 2021 Q2 | 397.33 Million USD | -0.86% |
| 2021 Q3 | 6.11 Billion USD | 1439.96% |
| 2021 Q4 | 5.59 Billion USD | -8.55% |
| 2020 Q2 | 413.8 Million USD | -2.52% |
| 2020 Q1 | 424.49 Million USD | -6.61% |
| 2020 Q3 | 412.41 Million USD | -0.33% |
| 2020 Q4 | 433.61 Million USD | 5.14% |
| 2020 FY | 433.61 Million USD | -4.61% |
| 2019 Q4 | 454.55 Million USD | 5.97% |
| 2019 FY | 454.55 Million USD | 30.15% |
| 2019 Q3 | 428.95 Million USD | -0.02% |
| 2019 Q1 | 432.52 Million USD | 23.84% |
| 2019 Q2 | 429.02 Million USD | -0.81% |
| 2018 Q1 | 348.98 Million USD | 0.03% |
| 2018 FY | 349.26 Million USD | 0.11% |
| 2018 Q4 | 349.26 Million USD | 0.03% |
| 2018 Q3 | 349.16 Million USD | 0.03% |
| 2018 Q2 | 349.07 Million USD | 0.03% |
| 2017 Q1 | 348.6 Million USD | 0.03% |
| 2017 FY | 348.88 Million USD | 0.11% |
| 2017 Q4 | 348.88 Million USD | 0.03% |
| 2017 Q3 | 348.79 Million USD | 0.03% |
| 2017 Q2 | 348.69 Million USD | 0.03% |
| 2016 FY | 348.51 Million USD | -0.43% |
| 2016 Q1 | 348.27 Million USD | -0.49% |
| 2016 Q2 | 348.32 Million USD | 0.01% |
| 2016 Q3 | 401.41 Million USD | 15.24% |
| 2016 Q4 | 348.51 Million USD | -13.18% |
| 2015 Q3 | 350 Million USD | 483.33% |
| 2015 FY | 350 Million USD | 0.0% |
| 2015 Q2 | 60 Million USD | 200.0% |
| 2015 Q1 | 20 Million USD | 0.0% |
| 2015 Q4 | 350 Million USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2012 Q1 | 20 Million USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2012 Q2 | - USD | -100.0% |
| 2011 Q1 | - USD | 0.0% |
| 2011 FY | - USD | -100.0% |
| 2011 Q4 | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2010 FY | 200 Thousand USD | -33.33% |
| 2010 Q1 | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2009 Q2 | 64.42 Million USD | -35.32% |
| 2009 FY | 300 Thousand USD | -99.72% |
| 2009 Q1 | 99.6 Million USD | -6.19% |
| 2009 Q3 | 28.5 Million USD | -55.75% |
| 2009 Q4 | - USD | -100.0% |
| 2008 Q2 | 107.43 Million USD | -18.08% |
| 2008 Q3 | 80.09 Million USD | -25.45% |
| 2008 FY | 106.17 Million USD | 11.91% |
| 2008 Q1 | 131.14 Million USD | 38.23% |
| 2008 Q4 | 106.17 Million USD | 32.57% |
| 2007 FY | 94.87 Million USD | 1737.65% |
| 2007 Q1 | 5.13 Million USD | -0.48% |
| 2007 Q4 | 94.87 Million USD | 34.47% |
| 2007 Q3 | 70.55 Million USD | 339.42% |
| 2007 Q2 | 16.05 Million USD | 212.51% |
| 2006 Q1 | 123 Thousand USD | -96.11% |
| 2006 FY | 5.16 Million USD | 3.1% |
| 2006 Q3 | 4.19 Million USD | 4093.0% |
| 2006 Q4 | 5.16 Million USD | 23.13% |
| 2006 Q2 | 100 Thousand USD | -18.7% |
| 2005 Q1 | - USD | -100.0% |
| 2005 FY | 5 Million USD | 2404.0% |
| 2005 Q4 | 3.16 Million USD | 1451.47% |
| 2005 Q3 | 204 Thousand USD | -54.67% |
| 2005 Q2 | 450 Thousand USD | 0.0% |
| 2004 Q3 | 7 Million USD | 3400.0% |
| 2004 Q2 | 200 Thousand USD | 0.0% |
| 2004 Q1 | - USD | -100.0% |
| 2004 FY | 200 Thousand USD | -97.19% |
| 2004 Q4 | 10 Million USD | 42.86% |
| 2003 Q1 | 10.5 Million USD | 20.85% |
| 2003 Q3 | 6.04 Million USD | -15.16% |
| 2003 FY | 7.12 Million USD | -39.33% |
| 2003 Q4 | 17.43 Million USD | 188.39% |
| 2003 Q2 | 7.12 Million USD | -32.15% |
| 2002 FY | 11.74 Million USD | 1.97% |
| 2002 Q4 | 8.69 Million USD | -21.47% |
| 2002 Q3 | 11.06 Million USD | -5.77% |
| 2002 Q2 | 11.74 Million USD | 14.9% |
| 2002 Q1 | 10.22 Million USD | -10.12% |
| 2001 Q1 | 352 Thousand USD | -91.21% |
| 2001 Q4 | 11.37 Million USD | 7.37% |
| 2001 FY | 11.51 Million USD | 315.51% |
| 2001 Q3 | 10.59 Million USD | -8.04% |
| 2001 Q2 | 11.51 Million USD | 3172.16% |
| 2000 Q1 | 1.99 Million USD | 99.2% |
| 2000 Q4 | 4 Million USD | -62.24% |
| 2000 Q3 | 10.6 Million USD | 282.4% |
| 2000 Q2 | 2.77 Million USD | 39.16% |
| 2000 FY | 2.77 Million USD | -23.0% |
| 1999 Q4 | 1 Million USD | 100.0% |
| 1999 FY | 3.6 Million USD | 0.0% |
| 1999 Q2 | 3.6 Million USD | 0.0% |
| 1999 Q3 | 500 Thousand USD | -86.11% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Bionano Genomics, Inc. | 87.94 Million USD | -4378.065% |
| Prenetics Global Limited | 2.36 Million USD | -166116.93% |
| Star Equity Holdings, Inc. | 3.6 Million USD | -109025.076% |
| CareDx, Inc | 34.22 Million USD | -11408.501% |
| Exact Sciences Corporation | 2.55 Billion USD | -54.158% |
| Exagen Inc. | 23.72 Million USD | -16502.69% |
| Inotiv, Inc. | 417.64 Million USD | -842.993% |
| Guardant Health, Inc. | 1.35 Billion USD | -190.917% |
| Biodesix, Inc. | 60.69 Million USD | -6389.14% |
| BioNexus Gene Lab Corp. | 133.39 Thousand USD | -2952277.525% |
| Precipio, Inc. | 1.11 Million USD | -352796.416% |
| iSpecimen Inc. | 196.24 Thousand USD | -2006750.655% |
| Natera, Inc. | 441.99 Million USD | -791.038% |
| Aspira Women's Health Inc. | 2.26 Million USD | -173700.706% |
| Standard BioTools Inc. | 98.21 Million USD | -3910.105% |
| 23andMe Holding Co. | 76.51 Million USD | -5047.127% |
| Castle Biosciences, Inc. | 15.31 Million USD | -25623.867% |
| Personalis, Inc. | 48.96 Million USD | -7943.634% |
| Aclaris Therapeutics, Inc. | 426 Thousand USD | -924389.202% |
| Applied DNA Sciences, Inc. | 1.23 Million USD | -318081.554% |
| OpGen, Inc. | 13.04 Million USD | -30093.29% |
| T2 Biosystems, Inc. | 49.49 Million USD | -7856.532% |
| Myriad Genetics, Inc. | 145 Million USD | -2616.086% |
| NeoGenomics, Inc. | 611.67 Million USD | -543.855% |
| Star Equity Holdings, Inc. | 3.6 Million USD | -109025.076% |
| IDEXX Laboratories, Inc. | 947.88 Million USD | -315.488% |
| RadNet, Inc. | 1.49 Billion USD | -164.119% |
| MDxHealth SA | 41.26 Million USD | -9443.982% |
| Psychemedics Corporation | 2.29 Million USD | -171280.505% |
| Illumina, Inc. | 2.26 Billion USD | -74.108% |
| Check-Cap Ltd. | - USD | -Infinity% |
| Twist Bioscience Corporation | 94.06 Million USD | -4086.633% |
| DarioHealth Corp. | 29.54 Million USD | -13231.722% |
| Fulgent Genetics, Inc. | 14.9 Million USD | -26319.293% |
| Sera Prognostics, Inc. | 1.85 Million USD | -211865.77% |
| ENDRA Life Sciences Inc. | 394.4 Thousand USD | -998453.256% |
| OPKO Health, Inc. | 326.56 Million USD | -1105.988% |
| Medpace Holdings, Inc. | 142.12 Million USD | -2671.087% |
| Neogen Corporation | 906.23 Million USD | -334.579% |
| Intelligent Bio Solutions Inc. | 871.44 Thousand USD | -451832.893% |
| Prenetics Global Limited | 2.36 Million USD | -166116.93% |
| Mainz Biomed B.V. | 7.42 Million USD | -52971.564% |
| bioAffinity Technologies, Inc. | 1.57 Million USD | -249375.909% |
| Trinity Biotech plc | 67.42 Million USD | -5740.871% |
| Neuronetics, Inc. | 62.47 Million USD | -6203.941% |
| Sotera Health Company | 2.32 Billion USD | -69.241% |
| bioAffinity Technologies, Inc. | 1.57 Million USD | -249375.909% |